{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:25:49Z","timestamp":1794097549009,"version":"4.8.0"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS\u20102023\u201000248157"],"award-info":[{"award-number":["RS\u20102023\u201000248157"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aims to compare adverse drug reaction patterns of liraglutide, semaglutide and tirzepatide\u2014glucagon\u2010like peptide\u20101 receptor agonists (GLP\u20101 RAs) approved for anti\u2010obesity medications\u2014to evaluate their real\u2010world safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>This disproportionality analysis utilized a case\u2013control design with VigiBase. The study focused on reports of adverse events associated with liraglutide, semaglutide and tirzepatide, selected based on warnings in the US Food and Drug Administration approval labels for each drug. Data were restructured using unique identifiers to differentiate individuals affected by adverse drug reactions. Multivariable logistic regression models estimated adjusted reporting odds ratios (aRORs) with 95% confidence intervals (CIs) to assess the association between various adverse events and GLP\u20101 RAs, adjusting for age, sex, region, reporter qualification, reporting year and concomitant medication. The information component (IC) was analysed, and signals of adverse drug reactions were considered significant only when both aROR and IC were statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our analysis of targeted adverse drug reactions included 24\u2009725 individuals using liraglutide, 21\u2009454 using semaglutide and 11\u2009538 using tirzepatide. Tirzepatide had fewer reports of adverse drug reactions compared with the other two drugs, and its pharmacovigilance association strength was the lowest. Semaglutide, however, was significantly associated with several unusual adverse events, including suicidal ideation and behaviour (IC, 1.53 [IC\n                      <jats:sub>025<\/jats:sub>\n                      , 1.28]; aROR, 2.52 [95% CI, 2.18\u20132.93]), hair loss (IC, 0.78 [IC\n                      <jats:sub>025<\/jats:sub>\n                      , 0.63]; aROR, 1.42 [95% CI, 1.30\u20131.55]) and vision loss (IC, 1.27 [IC\n                      <jats:sub>025<\/jats:sub>\n                      , 1.13]; aROR, 1.80 [95% CI, 1.66\u20131.97]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings emphasize the need for cautious prescribing and further research to ensure the safe use of these medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.16376","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T14:54:54Z","timestamp":1743778494000},"page":"3490-3502","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Adverse drug reaction patterns of\n                    <scp>GLP<\/scp>\n                    \u20101 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database"],"prefix":"10.1111","volume":"27","author":[{"given":"Tae Hyeon","family":"Kim","sequence":"first","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Medicine Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Regulatory Science Kyung Hee University  Seoul South Korea"},{"name":"Department of Precision Medicine Kyung Hee University College of Medicine  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongmin","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Regulatory Science Kyung Hee University  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Precision Medicine Kyung Hee University College of Medicine  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeon","family":"Oh","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Medicine Kyung Hee University College of Medicine  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyu","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Precision Medicine Kyung Hee University College of Medicine  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesu","family":"Jo","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Regulatory Science Kyung Hee University  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Biomedical Engineering Kyung Hee University  Yongin South Korea"},{"name":"Department of Electronics and Information Convergence Engineering Kyung Hee University  Yongin South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyeong","family":"Cho","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Medicine CHA University School of Medicine  Seongnam South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Clinical Research College of Pharmacy, University of Rhode Island  South Kingstown Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanseul","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Harvard T.H. Chan School of Public Health  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Medicine Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Family Medicine Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-9948","authenticated-orcid":false,"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[{"name":"Center for Digital Health Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Medicine Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Regulatory Science Kyung Hee University  Seoul South Korea"},{"name":"Department of Precision Medicine Kyung Hee University College of Medicine  Seoul South Korea"},{"name":"Department of Biomedical Engineering Kyung Hee University  Yongin South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02500-y"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0003"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00337-8"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19897"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP\u20101 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta\u2010analysis","volume":"384","author":"Yao H","year":"2024","journal-title":"BMJ"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.3732"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19574"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15864"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.104209"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2024.01536"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.10.001"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74729-2"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43588-021-00138-4"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.23385"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27424"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102684"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00861-y"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97233"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.001"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0016-2"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01992-4"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.02.006"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1364110"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1755"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.1531"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1202"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae260"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1001578"},{"key":"e_1_2_11_31_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078225","article-title":"Glucagon\u2010like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study","volume":"385","author":"Pasternak B","year":"2024","journal-title":"BMJ"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0701a01"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07613-w"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.6058"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-022-01258-0"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102427"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24539"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.964399"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00911-w"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.16376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:56:26Z","timestamp":1761893786000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.16376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/dom.16376"],"URL":"https:\/\/doi.org\/10.1111\/dom.16376","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.16376\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v1\/review4","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16376\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"2024-12-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}